EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, et al
These delivery platforms should incorporate stimuli-responsive release mechanisms, such as pH-sensitive or redox-sensitive components, to ensure precise spatiotemporal control of drug release within the TME
This leads to many GLP-1 drug misconceptions about the severity of treatment
That direct comparison not the placebo-controlled data presented today is what will define retatrutides actual clinical position and, ultimately, its payer negotiating leverage
Sin embargo, el tratamiento con ambos medicamentos tambin tiene inconvenientes: el equipo de Al-Aly descubri que, en los historiales mdicos asociados al uso de GLP-1RA, aparecan efectos secundarios como nuseas, vmitos y diarrea